More Rare Birds, and the Occasional Swan

Gastroenterology

Volumn 136, Issue 7, 2009, Pages 2412-2414

  Edlin, Brian R ^a   Shu, Marla A ^a   Winkelstein, Emily ^a   Des Jarlais, Don C ^b   Busch, Michael P ^c   Rehermann, Barbara ^d   O'Brien, Thomas R ^e   Talal, Andrew H ^f   Tobler, Leslie H ^g   Zeremski, Marija ^f   Beeder, Ann B ^f  

^a SUNY Downstate Medical Center   (United States)

^b BETH ISRAEL MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

^f WEILL CORNELL MEDICAL COLLEGE   (United States)

^g BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL FEATURE; HEALTH SERVICE; HEPATITIS B; HEPATITIS C; HEREDITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; LETTER; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEROCONVERSION; VIRUS INFECTION;

EID: 66449083013     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2009.04.040     Document Type: Letter

References (10)

1. Cox A.L., Page K., Bruneau J., et al. Rare birds in North America: acute hepatitis C cohorts. Gastroenterology 136 (2009) 26-31
2. Watters J.K., Estilo M.J., Clark G.L., et al. Syringe and needle exchange as HIV/AIDS prevention for injection drug users. JAMA 271 (1994) 115-120
3. Kral A.H., Bluthenthal R.N., Lorvick J., et al. Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Lancet 357 (2001) 1397-1401
4. Edlin B.R., Seal K.H., Lorvick J., et al. Is it justifiable to withhold treatment for hepatitis C from illicit-drug users?. N Engl J Med 345 (2001) 211-214
5. Tseng F.C., O'Brien T.R., Zhang M., et al. Seroprevalence of hepatitis B and C viruses among San Francisco Bay area injection drug users, 1998-2000. Hepatology 46 (2007) 666-671
6. Tseng F.C., Edlin B.R., Zhang M., et al. The inverse relationship between chronic HBV and HCV infections among injection drug users is associated with decades of age and drug use. J Viral Hepat 15 (2008) 690-698
7. Mizukoshi E., Eisenbach C., Edlin B.R., et al. Hepatitis C virus-specific immune responses of frequently exposed long-term injection drug users. J Infect Dis 198 (2008) 203-212
8. Page-Shafer K., Pappalardo B.L., Tobler L.H., et al. Testing strategy to identify cases of acute hepatitis C virus (HCV) infection and to project HCV incidence rates. J Clin Microbiol 46 (2008) 499-506
9. Zeremski M., Shu M.A., Brown Q., et al. Hepatitis C virus-specific T-cell immune responses in seronegative injection drug users. J Viral Hepat 16 (2009) 10-20
10. Edlin B.R., Carden M.R., and Ferrando S.J. Managing hepatitis C in users of illicit drugs. Curr Hepatitis Rep 6 (2007) 60-67